137 related articles for article (PubMed ID: 38800110)
1. Prolonged use of nomegestrol acetate and risk of intracranial meningioma: a population-based cohort study.
Nguyen P; Roland N; Neumann A; Hoisnard L; Passeri T; Duranteau L; Coste J; Froelich S; Zureik M; Weill A
Lancet Reg Health Eur; 2024 Jul; 42():100928. PubMed ID: 38800110
[TBL] [Abstract][Full Text] [Related]
2. Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study.
Weill A; Nguyen P; Labidi M; Cadier B; Passeri T; Duranteau L; Bernat AL; Yoldjian I; Fontanel S; Froelich S; Coste J
BMJ; 2021 Feb; 372():n37. PubMed ID: 33536184
[TBL] [Abstract][Full Text] [Related]
3. Risk of intracranial meningioma with three potent progestogens: A population-based case-control study.
Hoisnard L; Laanani M; Passeri T; Duranteau L; Coste J; Zureik M; Froelich S; Weill A
Eur J Neurol; 2022 Sep; 29(9):2801-2809. PubMed ID: 35621369
[TBL] [Abstract][Full Text] [Related]
4. Combined hormonal influence of cyproterone acetate and nomegestrol acetate on meningioma: a case report.
Champagne PO; Passeri T; Froelich S
Acta Neurochir (Wien); 2019 Mar; 161(3):589-592. PubMed ID: 30666456
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous regression of meningiomas after interruption of nomegestrol acetate: a series of three patients.
Passeri T; Champagne PO; Bernat AL; Hanakita S; Salle H; Mandonnet E; Froelich S
Acta Neurochir (Wien); 2019 Apr; 161(4):761-765. PubMed ID: 30783806
[TBL] [Abstract][Full Text] [Related]
6. Preliminary report of patients with meningiomas exposed to Cyproterone Acetate, Nomegestrol Acetate and Chlormadinone Acetate - Monocentric ongoing study on progestin related meningiomas.
Devalckeneer A; Aboukais R; Bourgeois P; De Witte O; Racape J; Caron S; Perbet R; Maurage CA; Lejeune JP
Clin Neurol Neurosurg; 2021 Nov; 210():106959. PubMed ID: 34592677
[TBL] [Abstract][Full Text] [Related]
7. Use of progestogens and the risk of intracranial meningioma: national case-control study.
Roland N; Neumann A; Hoisnard L; Duranteau L; Froelich S; Zureik M; Weill A
BMJ; 2024 Mar; 384():e078078. PubMed ID: 38537944
[TBL] [Abstract][Full Text] [Related]
8. Meningiomas in patients with long-term exposition to progestins: Characteristics and outcome.
Graillon T; Boissonneau S; Appay R; Boucekine M; Peyrière H; Meyer M; Farah K; Albarel F; Morange I; Castinetti F; Brue T; Fuentes S; Figarella-Branger D; Cuny T; Dufour H
Neurochirurgie; 2021 Nov; 67(6):556-563. PubMed ID: 33989642
[TBL] [Abstract][Full Text] [Related]
9. Opposed evolution of the osseous and soft parts of progestin-associated osteomeningioma after progestin intake discontinuation.
Florea SM; Passeri T; Abbritti R; Bernat AL; Fontanel S; Yoldjian I; Funck-Brentano T; Weill A; Mandonnet E; Froelich S
J Neurosurg; 2023 Oct; 139(4):944-952. PubMed ID: 36883659
[TBL] [Abstract][Full Text] [Related]
10. Progestin-related WHO grade II meningiomas behavior-a single-institution comparative case series.
Devalckeneer A; Aboukais R; Faisant M; Bourgeois P; Quentin VM; Maurage CA; Escande F; Lejeune JP
Neurosurg Rev; 2022 Apr; 45(2):1691-1699. PubMed ID: 34850321
[TBL] [Abstract][Full Text] [Related]
11. Prediction of nomegestrol acetate pharmacokinetics in healthy female adolescents and adults by whole-body physiology-based pharmacokinetic modelling and clinical validation.
Post TM; Gerrits M; Kerbusch T; de Greef R
Contraception; 2016 Feb; 93(2):133-8. PubMed ID: 26365792
[TBL] [Abstract][Full Text] [Related]
12. Meningioma in patients exposed to progestin drugs: results from a real-life screening program.
Samoyeau T; Provost C; Roux A; Legrand L; Dezamis E; Plu-Bureau G; Pallud J; Oppenheim C; Benzakoun J
J Neurooncol; 2022 Oct; 160(1):127-136. PubMed ID: 36066786
[TBL] [Abstract][Full Text] [Related]
13. Meningiomas and cyproterone acetate: a retrospective, monocentric cohort of 388 patients treated by surgery or radiotherapy for intracranial meningioma.
Samarut E; Lugat A; Amelot A; Scharbarg E; Hadjadj S; Primot C; Loussouarn D; Thillays F; Buffenoir K; Cariou B; Drui D; Roualdes V
J Neurooncol; 2021 Mar; 152(1):115-123. PubMed ID: 33392938
[TBL] [Abstract][Full Text] [Related]
14. Nomegestrol acetate/17-beta estradiol: a review of efficacy, safety, and patient acceptability.
Akintomide H; Panicker S
Open Access J Contracept; 2015; 6():77-86. PubMed ID: 29386925
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, tissue distribution, and excretion of nomegestrol acetate in female rats.
Huang Q; Chen X; Zhu Y; Cao L; Riviere JE
Eur J Drug Metab Pharmacokinet; 2015 Dec; 40(4):435-42. PubMed ID: 25168884
[TBL] [Abstract][Full Text] [Related]
16. Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea.
Grandi G; Napolitano A; Xholli A; Tirelli A; Di Carlo C; Cagnacci A
Gynecol Endocrinol; 2015 Oct; 31(10):774-8. PubMed ID: 26291811
[TBL] [Abstract][Full Text] [Related]
17. Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism.
Reed S; Koro C; DiBello J; Becker K; Bauerfeind A; Franke C; Heinemann K
Eur J Contracept Reprod Health Care; 2021 Dec; 26(6):439-446. PubMed ID: 34644228
[TBL] [Abstract][Full Text] [Related]
18. Cyproterone acetate and meningioma: a nationwide-wide population based study.
Champeaux-Depond C; Weller J; Froelich S; Sartor A
J Neurooncol; 2021 Jan; 151(2):331-338. PubMed ID: 33394263
[TBL] [Abstract][Full Text] [Related]
19. The effect of therapeutic and supratherapeutic oral doses of nomegestrol acetate (NOMAC)/17β-estradiol (E2) on QTcF intervals in healthy women: results from a randomized, double-blind, placebo- and positive-controlled trial.
de Kam PJ; van Kuijk J; Lillin O; Post T; Thomsen T
Clin Drug Investig; 2014 Jun; 34(6):413-20. PubMed ID: 24777591
[TBL] [Abstract][Full Text] [Related]
20. Nomegestrol acetate-17b-estradiol for oral contraception.
Burke A
Patient Prefer Adherence; 2013; 7():607-19. PubMed ID: 23836965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
